A Saudi Heart Association Position Statement on the use of DOACs in patients with Arterial and Venous Thrombosis
DOACs represent a valuable option for clinicians owing to their efficacy, safety and convenience compared to traditional anticoagulants. DOACs should be used based on individualized patient assessment, particularly regarding bleeding risk, stroke risk, and other comorbidities and clinical factors that may affect clinical outcomes. Adherence to the recommendations and guidance provided in this SHA statement is needed to enhance patient care and outcomes in Saudi Arabia.
Authors
- Waleed AlHabeeb (ORCID: https://orcid.org/0000-0003-2985-482X)
- Feras Khaliel
- Owayed Alshammeri
- Ayman M. Morsy
- Mohammed AlSheef (ORCID: https://orcid.org/0000-0003-1651-1158)
- Adel Tash (ORCID: https://orcid.org/0000-0001-7067-6303)
- Iman Alhazmi (ORCID: https://orcid.org/0000-0002-5417-9144)
- Ahmed Al‐Jedai (ORCID: https://orcid.org/0000-0002-4730-9086)
- Mohammed Arafah (ORCID: https://orcid.org/0000-0002-6664-4584)
- Saeed Alahmari
Institutions
- Alfaisal University (SA)
- Prince Sultan University (SA)
- King Faisal Specialist Hospital & Research Centre (SA)
- King Fahd Medical City (SA)
- King Saud University (SA)
- Saudi Heart Association (SA)
- King Fahd Armed Forces Hospital (SA)
- Saudi Health Council
Publication Details
- Journal
- Journal of the Saudi Heart Association
- Published
- 2025-03-20
- DOI
- https://doi.org/10.37616/2212-5043.1423
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00